wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36406541-061E0A5E-297D-4B64-B340-D5649A0BE1DF
Q36406541-061E0A5E-297D-4B64-B340-D5649A0BE1DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36406541-061E0A5E-297D-4B64-B340-D5649A0BE1DF
Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling.
P2860
Q36406541-061E0A5E-297D-4B64-B340-D5649A0BE1DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36406541-061E0A5E-297D-4B64-B340-D5649A0BE1DF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c13c31137a16506131653a03cda29d70ba90b2fd
P2860
Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus.